The continuous movement of the vocal cords weakens and eventually stops as laryngeal cancer progresses. Researchers have, for ...
Nearly 1 in 3 patients with connective tissue disease-associated interstitial lung disease will develop progressive pulmonary fibrosis.
Researchers discovered that exposing cancer cells to vibration mimicking vocal cord movement reduced their malignancy.
The University of Iowa Health Care Holden Comprehensive Cancer Center has started treating its second patient — the second in the state — with a cellular therapy to fight synovial sarcoma, a rare and ...
Researchers found vibration resembling vocal cord motion reduced cancer severity by lowering activity of a growth-related ...
The Hearty Soul on MSN
Doctors can spot diabetes and cancer in your eyes. Are you missing the signs?
The human eye is often described metaphorically as the "window to the soul," but in clinical medicine, it is more accurately viewed as a non-invasive window into the human body's circulatory and ...
Dedifferentiated liposarcoma lacks effective IGF-1→PPAR-γ adipogenic signaling due to epigenetic silencing of PPAR-γ2, with ...
Among the key speakers was Associate Professor Johnny Ong, Head and Senior Consultant of the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT) at the National Cancer Cen ...
11 天on MSN
Good vibrations: Playing music to cells reduces laryngeal cancer aggressiveness in lab tests
The continuous movement of the vocal cords weakens and eventually stops as laryngeal cancer progresses. Researchers have, for the first time, discovered that restoring cellular vibration reduces the ...
Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.
9 天on MSN
Which foods increase collagen naturally? Dermatologist picks 11 foods great for skin and bones
Collagen-rich foods: Dermatologist Jushya Bhatia Sarin shared insights on collagen-boosting foods, ranking them by their ...
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果